Investor Relations

Home > Investor Relations > IR Library > Balance Sheets (consolidated)

Balance Sheets (consolidated)

(million yen) 
  FY2016
(2016/4/1-2017/3/31)
FY2017
(2017/4/1-2018/3/31)
(Assets)
Current assets
   
Cash and deposits 9,444 14,247
Notes and accounts receivable 19,627 24,185
Electronically recorded monetary claims 6,597 6,278
Marketable securities 6,000 10,999
Finished products 22,510 17,609
Interim products 5,863 9,777
Raw materials and stored goods 11,157 8,951
Deferred tax assets 1,002 1,177
Currency swaps 1,841 506
Other current assets 2,511 2,006
Allowance for doubtful accounts 4 363
Total current assets 86,552 95,377
Fixed assets    
Buildings and structures (net) 29,830 34,722
Machineries, equipments and carriers (net) 15,148 12,807
Land 10,035 9,803
Constructions in progress 18,279 18,282
Other tangible fixed assets (net) 1,610 1,372
Total tangible fixed assets 74,904 76,989
Intangible fixed assets 1,894 1,936
Investments    
Investment securities 531 427
Stock of subsidiaries and associates 54 54
Deferred tax assets 13 -
Net defined benefit asset 40 36
Others 1,262 2,508
Allowance for doubtful accounts 6 5
Total investments and other assets 1,895 3,021
Total fixed assets 78,695 81,947
Total assets 165,247 177,325

(million yen) 
  FY2016 FY2017
(Liabilities)
Current liabilities
   
Trade notes and accounts payable 5,309 5,385
Electronically recorded obligations-operating 7,455 6,412
Short-term debt 1,740 850
Current portion of long-term debt 2,681 4,249
Accrued expenses 5,112 5,351
Accrued income taxes 885 2,766
Accrued bonuses for directors and Auditors 72 95
Notes payable-equipment 6,686 6,246
Accounts payable-equipment 3,679 2,384
Other current liabilities 978 2,162
Total current liabilities 34,601 35,904
Long-term liabilities    
Convertible bond 15,056 15,046
Long-term debt 39,253 44,803
Deferred tax liabilities 40 145
Net defined benefit liability 188 287
Accrued retirement benefits for directors and Auditors 154 128
Other long-term liabilities 1,007 1,090
Total long-term liabilities 55,701 61,501
Total liabilities 90,302 97,405
(Net Assets)
Shareholders' equity
   
Capital stock 4,717 4,717
Capital surplus 7,870 7,870
Retained earnings 67,879 72,816
Treasury stock 5,639 5,639
Total shareholders' equity 74,827 79,765
Other accumulated comprehensive income    
Difference on revaluation of marketable securities 85 147
Remeasurements of defined benefit plans 31 7
Total other accumulated comprehensive income 117 155
Total net assets 74,945 79,920
Total liabilities and net assets 165,247 177,325

Home > Investor Relations > IR Library > Balance Sheets (consolidated)
© Copyright TOWA PHARMACEUTICAL CO.,LTD. All Rights Reserved.